PSA after prostate surgery: a crystal ball for cancer?
NCT ID NCT07516886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 500 men who had their prostate removed for cancer. Researchers check PSA levels soon after surgery to see if they can predict if the cancer will come back or spread. No new treatments are given—just standard care and observation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lithuanian University of Health Sciences Hospital Kaunas Clinics, Department of Urology
RECRUITINGKaunas, Kauno, LT-50161, Lithuania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer spot prostate cancer return better than the standard scan?
- A sharper eye on prostate cancer return: PSMA PET vs. MRI
- AI may help spot dangerous prostate cancer and spare men from needless biopsies
- Blood test may spot prostate cancer without a needle
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Can a new drug combo tame resistant prostate cancer?